123
Views
9
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Platelet-derived growth factor receptor family mutations in gastrointestinal stromal tumours

, BSc, , , , , , & show all
Pages 805-811 | Received 07 Jun 2005, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jian-Hong Zhong, Liang Ma, Le-Qun Li, Hai-Ming Ru & Yin-Nong Zhao. (2011) Adjuvant imatinib for gastrointestinal stromal tumors: the current situation and problems. Scandinavian Journal of Gastroenterology 46:6, pages 645-651.
Read now

Articles from other publishers (8)

Mumini Wemimo Rasheed, Afolayan Enoch Abiodun, Uchechukwu Brian Eziagu, Najeem Adedamola Idowu, Abdullahi Kabiru, Taiwo Adeyemi Adegboye, Waheed Akanni Oluogun & Adekunle Adebayo Ayoade. (2023) Clinicopathological and Immunohistochemical Characterization of Gastrointestinal Stromal Tumour at Four Tertiary Health Centers in Nigeria Using CD117, DOG1, and Human Epidermal Growth Factor Receptor-2 Biomarkers. Annals of African Medicine 22:4, pages 501-507.
Crossref
Pieter A. Boonstra, Jourik A. Gietema, Albert J.H. Suurmeijer, Matthew R. Groves, Fernando de Assis Batista, Ed Schuuring & Anna K.L. Reyners. (2017) Tyrosine kinase inhibitor sensitive PDGFRΑ mutations in GIST: Two cases and review of the literature. Oncotarget 8:65, pages 109836-109847.
Crossref
Omar Abdel-Rahman. (2014) Targeting platelet-derived growth factor (PDGF) signaling in gastrointestinal cancers: preclinical and clinical considerations. Tumor Biology 36:1, pages 21-31.
Crossref
Jun Ohishi, Mikiko Aoki, Kazuki Nabeshima, Junji Suzumiya, Tamotsu Takeuchi, Akira Ogose, Michiyuki Hakozaki, Yuichi Yamashita & Hiroshi Iwasaki. (2013) Imatinib mesylate inhibits cell growth of malignant peripheral nerve sheath tumors in vitro and in vivothrough suppression of PDGFR-β. BMC Cancer 13:1.
Crossref
Oddvar M. Sandvik, Kjetil Søreide, Jan Terje Kvaløy, Einar Gudlaugsson & Jon Arne Søreide. (2011) Epidemiology of gastrointestinal stromal tumours: Single-institution experience and clinical presentation over three decades. Cancer Epidemiology 35:6, pages 515-520.
Crossref
Jana Fassunke, Marie-Christine Blum, Hans-Ulrich Schildhaus, Marc Zapatka, Benedikt Brors, Helen Künstlinger, Reinhard Büttner, Eva Wardelmann & Sabine Merkelbach-Bruse. (2010) qPCR in gastrointestinal stromal tumors: Evaluation of reference genes and expression analysis of KIT and the alternative receptor tyrosine kinases FLT3, CSF1-R, PDGFRB, MET and AXL. BMC Molecular Biology 11:1.
Crossref
G.F. Samelis, K.A. Ekmektzoglou & G.C. Zografos. (2007) Gastrointestinal stromal tumours: Clinical overview, surgery and recent advances in imatinib mesylate therapy. European Journal of Surgical Oncology (EJSO) 33:8, pages 942-950.
Crossref
Mikiko Aoki, Kazuki Nabeshima, Kaori Koga, Makoto Hamasaki, Junji Suzumiya, Kazuo Tamura & Hiroshi Iwasaki. (2007) Imatinib mesylate inhibits cell invasion of malignant peripheral nerve sheath tumor induced by platelet-derived growth factor-BB. Laboratory Investigation 87:8, pages 767-779.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.